CRNX vs MSFT: Which Stock is Better?
Side-by-side comparison of Crinetics Pharmaceuticals Inc and Microsoft Corporation in 2026
CRNX
Crinetics Pharmaceuticals Inc
$84.95
MSFT
Microsoft Corporation
$498.10
Key Metrics Comparison
| Metric | CRNX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.76B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | CRNX |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 158.4% | 18.4% | CRNX |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze CRNX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CRNX or MSFT a better investment?
Comparing CRNX and MSFT: Crinetics Pharmaceuticals Inc has a market cap of $2.76B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CRNX and MSFT?
CRNX (Crinetics Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CRNX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CRNX or MSFT?
CRNX has higher revenue growth at 158.4% vs 18.4% for MSFT.
Which company is more profitable: CRNX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for CRNX.
Which is the larger company: CRNX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $2.76B for CRNX.
Should I buy CRNX or MSFT in 2026?
Both CRNX and MSFT have investment merit. CRNX trades at $84.95 while MSFT trades at $498.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CRNX and MSFT stock?
Key differences: Market Cap ($2.76B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (158.4% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy CRNX or MSFT in 2026?
The choice between CRNX and MSFT depends on your investment goals. CRNX shows higher revenue growth (158.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CRNX and MSFT?
CRNX (Crinetics Pharmaceuticals Inc) has a market cap of $2.76B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.